Search Results - "Alabdullah, Muslim"
-
1
The silibinin-loaded Zein-β cyclodextrin nano-carriers (SZBC-NCs) as a novel selective cancer cell drug delivery system in HT-29 cell line
Published in Scientific reports (26-06-2024)“…Entrapping phytochemical bioactive compounds into nano-structured biocompatible polymers has been successfully utilized for improving cancer treatment…”
Get full text
Journal Article -
2
Molecular disruption of DNA polymerase β for platinum sensitisation and synthetic lethality in epithelial ovarian cancers
Published in Oncogene (08-04-2021)“…Targeting PARP1 [Poly(ADP-Ribose) Polymerase 1] for synthetic lethality is a new strategy for BRCA germ-line mutated or platinum sensitive ovarian cancers…”
Get full text
Journal Article -
3
RAD50 deficiency is a predictor of platinum sensitivity in sporadic epithelial ovarian cancers
Published in Molecular biomedicine (30-12-2020)“…Intrinsic or acquired resistance seriously limits the use of platinating agents in advanced epithelial ovarian cancers. Increased DNA repair capacity is a key…”
Get full text
Journal Article -
4
Clinicopathological and Functional Evaluation Reveal NBS1 as a Predictor of Platinum Resistance in Epithelial Ovarian Cancers
Published in Biomedicines (08-01-2021)“…Platinum resistance seriously impacts on the survival outcomes of patients with ovarian cancers. Platinum-induced DNA damage is processed through DNA repair…”
Get full text
Journal Article -
5
ATM Regulated PTEN Degradation Is XIAP E3 Ubiquitin Ligase Mediated in p85α Deficient Cancer Cells and Influence Platinum Sensitivity
Published in Cells (Basel, Switzerland) (18-10-2019)“…Ataxia-telegiectasia mutated (ATM), phosphatase and tensin homolog (PTEN), and p85α are key tumour suppressors. Whether ATM regulates PTEN expression and…”
Get full text
Journal Article -
6
Exploring the Role of Cell Signalling and Dna Damage Pathways in Primary Surgically Resected Ovarian Cancer
Published 01-01-2021“…Background: Ovarian cancer (OC) is the most lethal gynaecologic malignancy. It is a heterogeneous disease at the molecular, histological and clinical levels…”
Get full text
Dissertation -
7
PARP1 blockade is synthetically lethal in XRCC1 deficient sporadic epithelial ovarian cancers
Published in Cancer letters (28-01-2020)“…PARP1 inhibitor (Niraparib, Olaparib, Rucaparib) maintenance therapy improves progression-free survival in platinum sensitive sporadic epithelial ovarian…”
Get full text
Journal Article -
8
ERCC1-XPF deficiency is a predictor of olaparib induced synthetic lethality and platinum sensitivity in epithelial ovarian cancers
Published in Gynecologic oncology (01-05-2019)“…PARP inhibitor maintenance therapy in platinum sensitive sporadic ovarian cancers improves progression free survival. However, biomarker for synthetic…”
Get full text
Journal Article -
9
Molecular disruption of DNA polymerase [beta] for platinum sensitisation and synthetic lethality in epithelial ovarian cancers
Published in Oncogene (08-04-2021)“…Targeting PARP1 [Poly(ADP-Ribose) Polymerase 1] for synthetic lethality is a new strategy for BRCA germ-line mutated or platinum sensitive ovarian cancers…”
Get full text
Journal Article -
10
Ligase 1 is a predictor of platinum resistance and its blockade is synthetically lethal in XRCC1 deficient epithelial ovarian cancers
Published in Theranostics (01-01-2021)“…The human ligases (LIG1, LIG3 and LIG4) are essential for the maintenance of genomic integrity by catalysing the formation of phosphodiester bonds between…”
Get full text
Journal Article